---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-035863"
form_type: "8-K"
ticker: "ANGO"
cik: "0001275187"
company_name: "ANGIODYNAMICS INC"
filed_at: "2023-07-24T23:59:59+00:00"
generated_at: "2026-06-13T04:04:25.610594+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Board adds Lorinda Burgess; director equity grants fully vested

## Summary
- Lorinda Burgess appointed as Class III director effective July 19, 2023, expanding board to nine members.
- Burgess brings 35+ years experience, including 15+ years at Medtronic as Vice President of Finance, Americas Region.
- Burgess was appointed to the Audit Committee and Compensation Committee of the Board.
- Non-employee director annual equity grants changed to be fully vested at time of grant.

## SEC filing metadata
- accession: 0001140361-23-035863
- form_type: 8-K
- ticker: ANGO
- cik: 0001275187
- company_name: ANGIODYNAMICS INC
- filed_at: 2023-07-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1275187/000114036123035863/0001140361-23-035863-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1275187/000114036123035863/brhc20056191_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-035863
- JSON: https://secwatch.observer/filing/0001140361-23-035863.json
- Plain text: https://secwatch.observer/filing/0001140361-23-035863.txt

## Key facts
- Executive change
  Lorinda Burgess was appointed as Class III Director at ANGIODYNAMICS INC.
  - Action: appointed
  - Role: Class III Director
  source text: On July 19, 2023, the board of directors (the “Board”) of AngioDynamics, Inc. (“AngioDynamics”) approved an increase in the size of the Board to a total of nine directors and appointed Lorinda Burgess as a Class III director of AngioDynamics, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1275187/000114036123035863/0001140361-23-035863-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.